Nygaard, B.
, Saedder, E. A., Dalhoff, K., Wikkelsoe, M. & Jürgens, G. (2015).
Levothyroxine Poisoning - Symptoms and Clinical Outcome.
Basic & Clinical Pharmacology & Toxicology,
117(4), 280-5.
https://doi.org/10.1111/bcpt.12401
Norris, A. W., Hirshman, M. F., Yao, J.
, Jessen, N., Musi, N., Chen, L., Sivitz, W. I., Goodyear, L. J. & Kahn, C. R. (2008).
Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle.
Endocrinology,
149(11), 5374-83.
https://doi.org/10.1210/en.2008-0100
Nøhr, M. K., Dudele, A., Poulsen, M. M., Ebbesen, L. H., Radko, Y., Christensen, L. P.
, Jessen, N., Richelsen, B., Lund, S. & Pedersen, S. B. (2016).
LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol.
PLOS ONE,
11(1), Artikel e0146840.
https://doi.org/10.1371/journal.pone.0146840
Nielsen, C.
, Gormsen, L. C., Jessen, N., Pedersen, S. B., Møller, N., Lund, S. & Jørgensen, J. O. L. (2008).
Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
Journal of Clinical Endocrinology and Metabolism,
93(7), 2842-50.
https://doi.org/10.1210/jc.2007-2414
Nielsen, T. S., Vendelbo, M. H., Jessen, N., Pedersen, S. B., Jørgensen, J. O., Lund, S. & Møller, N. (2011).
Fasting, but not exercise, increases adipose triglyceride lipase (ATGL) protein and reduces G(0)/G(1) switch gene 2 (G0S2) protein and mRNA content in human adipose tissue.
Journal of Clinical Endocrinology and Metabolism,
96(8), E1293-7.
https://doi.org/10.1210/jc.2011-0149
Nielsen, T. S., Opstrup, U. K., Nielsen, B. R. R., Jessen, N., Orskov, L.
, Pedersen, S. B., Jørgensen, J. O., Lund, S. & Møller, N. (2012).
Reduced mRNA and Protein Expression of Perilipin A and G0/G1 Switch Gene 2 (G0S2) in Human Adipose Tissue in Poorly Controlled Type 2 Diabetes.
Journal of Clinical Endocrinology and Metabolism,
97(7), E1348-1352 .
https://doi.org/10.1210/jc.2012-1159
Nielsen, T. S.
, Jessen, N., Jørgensen, J. O. L., Møller, N. & Lund, S. (2014).
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
Journal of Molecular Endocrinology,
52(3), R199-222.
https://doi.org/10.1530/JME-13-0277
Nielsen, E. S., Hellfritzsch, M., Sørensen, M. J., Rasmussen, H., Thomsen, P. H. & Laursen, T. (2015).
Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic.
European Child & Adolescent Psychiatry,
25(1), 25-31.
https://doi.org/10.1007/s00787-015-0699-z
Nellemann, B., Vendelbo, M. H., Nielsen, T. S., Bak, A. M., Høgild, M.
, Pedersen, S. B., Biensø, R. S., Pilegaard, H.
, Møller, N., Jessen, N. & Jørgensen, J. O. L. (2014).
Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity.
Acta Physiologica (Print),
210(2), 392-402.
https://doi.org/10.1111/apha.12183
Nellemann, B., Søndergaard, E., Jensen, J., Pedersen, S. B., Jessen, N., Jørgensen, J. O. L. & Nielsen, S. (2014).
Kinetics and utilization of lipid sources during acute exercise and acipimox.
A J P: Endocrinology and Metabolism (Online),
307(2), E199-208.
https://doi.org/10.1152/ajpendo.00043.2014
Møller, N., Gormsen, L. C., Schmitz, O., Lund, S., Jørgensen, J. O. L. & Jessen, N. (2009).
Free fatty acids inhibit growth hormone/signal transducer and activator or transcription-5 in signaling in human muscle: a potential feedback mechanism.
Journal of Clinical Endocrinology and Metabolism,
94, 2204-2207.
https://doi.org/10.1210/jc.2008-2624
Møller, L., Nørrelund, H., Jessen, N., Flyvbjerg, A., Pedersen, S. B., Gaylinn, B. D., Liu, J., Thorner, M. O.
, Møller, N. & Jørgensen, J. O. L. (2009).
Impact of Growth Hormone Receptor Blockade on Substrate Metabolism during Fasting in Healthy Subjects.
Journal of Clinical Endocrinology and Metabolism,
94(11), 4524-4532.
https://doi.org/10.1210/jc.2009-0381
Møller, A. B., Vendelbo, M. H., Christensen, B., Clasen, B. F. F., Bak, A. M., Jørgensen, J. O. L., Møller, N. & Jessen, N. (2015).
Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle.
Journal of Applied Physiology,
118(8), 971-9.
https://doi.org/10.1152/japplphysiol.01116.2014
Miller, J.
, Pedersen, L. H., Streja, E.
, Bech, B. H., Yeargin-Allsopp, M., Van Naarden Braun, K., Schendel, D., Christensen, D., Uldall, P.
& Olsen, J. (2013).
Maternal infections during pregnancy and cerebral palsy: a population-based cohort study.
Miller, J. E., Pedersen, L. H., Streja, E., Bech, B. H., Yeargin-Allsopp, M., Van Naarden Braun, K.
, Schendel, D. E., Christensen, D., Uldall, P. V.
& Olsen, J. (2013).
Maternal Infections during Pregnancy and Cerebral Palsy: A Population-based Cohort Study.
Paediatric and Perinatal Epidemiology (Print),
27(6), 542-552.
https://doi.org/10.1111/ppe.12082
Marren, A. J., Mogra, R.
, Pedersen, L. H., Walter, M., Ogle, R. F. & Hyett, J. A. (2014).
Ultrasound assessment of cervical length at 18-21 weeks' gestation in an Australian obstetric population: Comparison of transabdominal and transvaginal approaches.
The Australian and New Zealand Journal of Obstetrics and Gynaecology.
https://doi.org/10.1111/ajo.12204
Marier, J.-F., Lor, M., Morin, J., Roux, L., Di Marco, M., Morelli, G.
& Saedder, E. A. (2007).
Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation.
British Journal of Clinical Pharmacology. Supplement,
63(1), 121-4.
https://doi.org/10.1111/j.1365-2125.2006.02758.x
Marier, J.-F., Lor, M., Potvin, D., Dimarco, M., Morelli, G.
& Saedder, E. A. (2006).
Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
The Journal of Clinical Pharmacology,
46(6), 642-53.
https://doi.org/10.1177/0091270006286901
Mao, Y., Pedersen, L. H., Christensen, J., Vestergaard, M., Zhou, W.
, Olsen, J. & Sun, Y. (2016).
Prenatal exposure to antidepressants and risk of epilepsy in childhood.
Pharmacoepidemiology and Drug Safety,
25(11), 1320–1330.
https://doi.org/10.1002/pds.4072
Madsen, M., Hafstrøm, T. K., Møller, L., Christensen, B., Vendelbo, M. H., Pedersen, S. B., Frystyk, J., Jessen, N., Hansen, T. K., Stødkilde-Jørgensen, H., Flyvbjerg, A. & Jørgensen, J. O. L. (2012).
Fat Content in Liver and Skeletal Muscle Changes in a Reciprocal Manner in Patients with Acromegaly during Combination Therapy with a Somatostatin Analog and a GH Receptor Antagonist: A Randomized Clinical Trial.
Journal of Clinical Endocrinology and Metabolism.
https://doi.org/10.1210/jc.2011-2681
Ma, Z., Parkner, T., Frystyk, J., Laursen, T., Lauritzen, T. & Christiansen, J. S. (2012).
A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study.
Diabetes Technology & Therapeutics,
14(7), 589-95.
https://doi.org/10.1089/dia.2011.0299
Ma, Z., Christiansen, J. S., Laursen, T., Wu, C., Lauritzen, T., Parkner, T. & Frystyk, J. (2014).
Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes.
B M C Endocrine Disorders,
14(35).
https://doi.org/10.1186/1472-6823-14-35
Ma, Z., Christiansen, J. S., Laursen, T., Lauritzen, T. & Frystyk, J. (2014).
Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes.
European Journal of Endocrinology,
171(4), 471-9.
https://doi.org/10.1530/EJE-14-0258
Liu, X., Olsen, J., Pedersen, L. H., Agerbo, E., Yuan, W.
& Li, J. (2015).
Antidepressant use during pregnancy and asthma in the offspring.
Pediatrics,
135(4), e911-7.
https://doi.org/10.1542/peds.2014-4073
Liu, X., Liew, Z.
, Olsen, J., Pedersen, L. H., Bech, B. H., Agerbo, E., Yuan, W.
& Li, J. (2016).
Association of prenatal exposure to acetaminophen and coffee with childhood asthma.
Pharmacoepidemiology and Drug Safety,
25(2), 188-195.
https://doi.org/10.1002/pds.3940
Lihn, A. S.
, Jessen, N., Richelsen, B., Pedersen, S. B. & Lund, S. (2004).
AICAR stimulates adiponectin and inhibits cytokines in adipose tissue.
Biochen Biophys Res Commun,
316, 853-858.
Leung, C., Saaid, R.
, Pedersen, L. H., Park, F., Poon, L. & Hyett, J. (2015).
Demographic factors that can be used to predict early-onset pre-eclampsia.
Journal of Maternal - Fetal & Neonatal Medicine,
28(5), 535–539.
https://doi.org/10.3109/14767058.2014.923837
Lerin, C., Goldfine, A. B., Boes, T., Liu, M., Kasif, S., Dreyfuss, J. M., De Sousa-Coelho, A. L., Daher, G., Manoli, I., Sysol, J. R., Isganaitis, E.
, Jessen, N., Goodyear, L. J., Beebe, K., Gall, W., Venditti, C. P. & Patti, M.-E. (2016).
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism.
Molecular Metabolism,
5(10), 926-36.
https://doi.org/10.1016/j.molmet.2016.08.001
Laursen, T., Gravholt, C. H., Heickendorff, L., Drustrup, J., Kappelgaard, A. M.
, Jørgensen, J. O. L. & Christiansen, J. S. (2001).
Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoproteinmetabolism in GH-deficient adults.
Journal of Clinical Endocrinology and Metabolism,
86(3), 1222-1228.
Laursen, T., Gravholt, C. H., Heickendorff, L., Drustrup, J., Kappelgaard, A. M., Jørgensen, J. O. L. & Christiansen, J. S. (2001).
Long-term effects of continuous subcutaneous (sc) infusion versus daily injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, bone and lipoprotein metabolism inGH-deficient adults.
Journal of Clinical Endocrinology and Metabolism,
86, 1222-1228.
Laursen, T., Mindeholm, L., Haemmerle, S., Ferreira, A.
, Jørgensen, J. O. L., Azria, M.
& Christiansen, J. S. (2007).
A novel oral preparation of human growth hormone (hGH) is absorbed and increases serum IGF-I levels after 7 days administration to GH-deficient adults. I
Clinical - Physiology & Pharmacology of the Growth Hormone Axis: New Treatment Modalities & Indications US Endocrine Society.